Tumor-Localized Co-Stimulatory T-Cell Engagement by the 4-1BB/ HER2 Bispecific

Time: 9:30 am
day: Day Two


• Exploring the drug discovery process: target identification and validation, antitumor effect, pathway understanding, biomarkers
• Discussing potential indications
• Forecasting the future to be monotherapy and/or combination dominated
• Discussing the biomarker and patient status
• Latest data and future directions